14-day Premium Trial Subscription Try For FreeTry Free
$1.32
+0 (+0%)
At Close: May 03, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile
Date Action Amount Person Type
Mar 01, 2024 Buy 579 100 Germa Caroline Stock Option (Right to Buy)
Feb 29, 2024 Buy 0 Germa Caroline
Feb 01, 2024 Buy 100 000 Ecsedy Jeffrey Stock Option (Right to Buy)
Feb 01, 2024 Buy 181 000 Marango Jotin Stock Option (Right to Buy)
Feb 01, 2024 Buy 320 000 Manfredi Mark Stock Option (Right to Buy)
Aug 04, 2023 Buy 153 121 Bonita David P Non-Voting Common Stock
Aug 04, 2023 Buy 353 192 Bonita David P Series A Preferred Stock
Aug 04, 2023 Buy 153 121 Orbimed Advisors Llc Non-Voting Common Stock
Aug 04, 2023 Buy 353 192 Orbimed Advisors Llc Series A Preferred Stock
Aug 04, 2023 Buy 153 121 Orbimed Advisors Llc Common Stock
Aug 04, 2023 Buy 353 192 Orbimed Advisors Llc Series A Preferred Stock
Aug 04, 2023 Buy 153 121 Bonita David P Common Stock
Aug 04, 2023 Buy 353 192 Bonita David P Series A Preferred Stock
Jun 09, 2023 Buy 17 520 Dukes Iain D. Stock Option (Right to Buy)
Jun 09, 2023 Buy 17 520 Hughes Owen Stock Option (Right to Buy)
Jun 09, 2023 Buy 17 520 Stampacchia Otello Stock Option (Right to Buy)
Jun 09, 2023 Buy 17 520 Bonita David P Stock Option (Right to Buy)
Jun 09, 2023 Buy 17 520 Koehler Maria Stock Option (Right to Buy)
Jun 09, 2023 Buy 17 520 Wooster Richard Stock Option (Right to Buy)
Jun 09, 2023 Buy 17 520 Formela Jean Francois Stock Option (Right to Buy)
Jan 03, 2023 Buy 105 000 Santillana Sergio L. Stock Option (Right to Buy)
Jan 03, 2023 Buy 105 000 Ecsedy Jeffrey Stock Option (Right to Buy)
Jan 03, 2023 Buy 105 000 Zhang Xiaoyan Michelle Stock Option (Right to Buy)
Jan 03, 2023 Buy 220 000 Manfredi Mark Stock Option (Right to Buy)
Jan 03, 2023 Buy 105 000 Marango Jotin Stock Option (Right to Buy)
Dec 15, 2022 Buy 35 040 Hughes Owen Stock Option (Right to Buy)
Dec 14, 2022 Buy 0 Hughes Owen
Dec 14, 2022 Buy 0 Hughes Owen
Jun 24, 2022 Sell 96 035 Orbimed Advisors Llc Common Stock
Jun 24, 2022 Sell 65 965 Orbimed Advisors Llc Common Stock
Jun 24, 2022 Sell 96 035 Bonita David P Common Stock
Jun 24, 2022 Sell 65 965 Bonita David P Common Stock
Jun 23, 2022 Sell 23 419 Orbimed Advisors Llc Common Stock
Jun 22, 2022 Sell 66 806 Orbimed Advisors Llc Common Stock
Jun 22, 2022 Sell 66 806 Orbimed Genesis Gp Llc Common Stock
Jun 22, 2022 Sell 23 419 Bonita David P Common Stock
Jun 22, 2022 Sell 66 806 Bonita David P Common Stock
Jun 09, 2022 Buy 13 419 Stampacchia Otello Stock Option (Right to Buy)
Jun 09, 2022 Buy 13 419 Dukes Iain D. Stock Option (Right to Buy)
Jun 09, 2022 Buy 13 419 Dukes Iain D. Stock Option (Right to Buy)
Jun 09, 2022 Buy 13 419 Renaud Ronald C Jr Stock Option (Right to Buy)
Jun 09, 2022 Buy 13 419 Formela Jean Francois Stock Option (Right to Buy)
Jun 09, 2022 Buy 13 419 Bonita David P Stock Option (Right to Buy)
Jun 09, 2022 Buy 13 419 Bonita David P Stock Option (Right to Buy)
Jun 09, 2022 Buy 13 419 Wooster Richard Stock Option (Right to Buy)
Jun 09, 2022 Buy 13 419 Wooster Richard Stock Option (Right to Buy)
Jun 09, 2022 Buy 13 419 Koehler Maria Stock Option (Right to Buy)
Jun 09, 2022 Buy 13 419 Koehler Maria Stock Option (Right to Buy)
Apr 25, 2022 Buy 397 199 Marango Jotin Stock Option (Right to Buy)
Apr 25, 2022 Buy 397 199 Marango Jotin Stock Option (Right to Buy)
Apr 25, 2022 Buy 0 Marango Jotin
Feb 18, 2022 Buy 30 192 Oliveira Francisco Stock Option (Right to Buy)
Feb 18, 2022 Buy 11 182 Oliveira Francisco Stock Option (Right to Buy)
Feb 18, 2022 Buy 30 600 Oliveira Francisco Stock Option (Right to Buy)
Feb 03, 2022 Buy 238 900 Manfredi Mark Stock Option (Right to Buy)
Feb 02, 2022 Buy 40 000 Zhang Xiaoyan Michelle Stock Option (Right to Buy)
Feb 02, 2022 Buy 70 400 Santillana Sergio L. Stock Option (Right to Buy)
Feb 02, 2022 Buy 59 360 Ecsedy Jeffrey Stock Option (Right to Buy)
Feb 02, 2022 Buy 40 000 Tessier Maude Stock Option (Right to Buy)
Jan 21, 2022 Buy 29 200 Wooster Richard Stock Option (Right to Buy)
Jan 21, 2022 Buy 0 Wooster Richard
Jan 18, 2022 Buy 8 265 Tessier Maude Common Stock
Jan 18, 2022 Buy 24 606 Tessier Maude Common Stock
Jan 18, 2022 Buy 38 915 Tessier Maude Common Stock
Jan 18, 2022 Sell 8 265 Tessier Maude Stock Option (Right to Buy)
Jan 18, 2022 Sell 24 606 Tessier Maude Stock Option (Right to Buy)
Jan 18, 2022 Sell 38 915 Tessier Maude Stock Option (Right to Buy)
Jan 11, 2022 Buy 964 Zhang Xiaoyan Michelle Common Stock
Jan 11, 2022 Sell 964 Zhang Xiaoyan Michelle Common Stock
Jan 11, 2022 Sell 964 Zhang Xiaoyan Michelle Stock Option (Right to Buy)
Jan 10, 2022 Buy 36 Zhang Xiaoyan Michelle Common Stock
Jan 10, 2022 Sell 36 Zhang Xiaoyan Michelle Stock Option (Right to Buy)
Dec 21, 2021 Buy 13 419 Koehler Maria Stock Option (Right to Buy)
Dec 21, 2021 Buy 13 419 Stampacchia Otello Stock Option (Right to Buy)
Dec 21, 2021 Buy 13 419 Formela Jean Francois Stock Option (Right to Buy)
Dec 21, 2021 Buy 23 419 Dukes Iain D. Stock Option (Right to Buy)
Dec 21, 2021 Buy 13 419 Renaud Ronald C Jr Stock Option (Right to Buy)
Dec 21, 2021 Buy 13 419 Bonita David P Stock Option (Right to Buy)
Dec 14, 2021 Sell 5 959 Formela Jean Francois Common Stock
Dec 14, 2021 Sell 5 959 Atlas Venture Fund Xi, L.p. Common Stock
Dec 13, 2021 Sell 8 330 Formela Jean Francois Common Stock
Dec 13, 2021 Sell 8 330 Atlas Venture Fund Xi, L.p. Common Stock
Dec 10, 2021 Buy 1 000 Zhang Xiaoyan Michelle Common Stock
Dec 10, 2021 Sell 1 000 Zhang Xiaoyan Michelle Common Stock
Dec 10, 2021 Sell 1 000 Zhang Xiaoyan Michelle Stock Option (Right to Buy)
Dec 10, 2021 Sell 11 989 Formela Jean Francois Common Stock
Dec 10, 2021 Sell 11 989 Atlas Venture Fund Xi, L.p. Common Stock
Nov 22, 2021 Buy 176 699 Zhang Xiaoyan Michelle Stock Option (Right to Buy)
Nov 22, 2021 Buy 0 Zhang Xiaoyan Michelle Common Stock
Nov 22, 2021 Buy 19 427 Zhang Xiaoyan Michelle Stock Option (Right to Buy)
Nov 22, 2021 Buy 26 473 Zhang Xiaoyan Michelle Stock Option (Right to Buy)
Nov 22, 2021 Buy 55 912 Zhang Xiaoyan Michelle Stock Option (Right to Buy)
Apr 15, 2021 Buy 26 838 Koehler Maria Stock Option (Right to Buy)
Apr 15, 2021 Buy 26 838 Koehler Maria Stock Option (Right to Buy)
Apr 15, 2021 Buy 0 Koehler Maria
Mar 30, 2021 Buy 125 000 Formela Jean Francois Common Stock
Mar 30, 2021 Buy 125 000 Atlas Venture Fund Xi, L.p. Common Stock
Mar 30, 2021 Buy 5 429 023 Bonita David P Non-Voting Common Stock
Mar 30, 2021 Buy 375 000 Bonita David P Common Stock
Dec 21, 2020 Buy 8 938 148 Bonita David P Series B Preferred Stock
JSON CSV
INSIDER POWER
87.917
Last 100 transactions
Buy: 20 983 531 | Sell: 699 562 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 87.917.

In total, the insiders bought 20 983 531 and sold 699 562 IKNA shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Ikena Oncology, Inc.

Ikena Oncology. Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. It is also developing a small molecule inhibitor program against ERK5 in the RAS signaling pathway; IK-1... IKNA Profile

Golden Star

Ticker Date Change Price
BSCQ Apr 30 0.393% $19.09
EQC Apr 30 1.76% $18.72
HRB Apr 30 1.69% $47.23
REG Apr 30 1.35% $59.22
INGR Apr 30 0.576% $114.59
BSJP Apr 29 0.175% $22.91
LYG Apr 29 0.781% $2.56
ORA Apr 29 3.46% $64.48
DHT Apr 24 4.34% $11.28
LPLA Apr 19 2.62% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT